Direct-acting Antivirals for Hepatitis C Infection Are Underused in the US, Study Finds - Pharmacy Times
While the use of direct-acting antiviral treatment for hepatitis C virus increased from 2014 to 2018, treatment rates have declined since 2019 and remain suboptimal. - READ MORE